Interleukin-23 monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-23 monoclonal antibody, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety [Phase 4]